DrugPatentWatch Database Preview
Chartwell Rx Company Profile
What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?
CHARTWELL RX has forty-six approved drugs.
Summary for Chartwell Rx
| US Patents: | 0 |
| Tradenames: | 25 |
| Ingredients: | 22 |
| NDAs: | 46 |
Drugs and US Patents for Chartwell Rx
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 081265-001 | Jan 23, 1992 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Chartwell Rx | TRICHLORMETHIAZIDE | trichlormethiazide | TABLET;ORAL | 085568-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Chartwell Rx | CAM-METRAZINE | phendimetrazine tartrate | TABLET;ORAL | 085321-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
